Detalles de la búsqueda
1.
The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation.
Nat Immunol
; 20(5): 571-580, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30936493
2.
ARL5b inhibits human rhinovirus 16 propagation and impairs macrophage-mediated bacterial clearance.
EMBO Rep
; 25(3): 1156-1175, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38332148
3.
IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels.
Am J Respir Crit Care Med
; 208(10): 1075-1087, 2023 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708400
4.
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
Eur Respir J
; 61(4)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36229046
5.
Arpin is critical for phagocytosis in macrophages and is targeted by human rhinovirus.
EMBO Rep
; 21(1): e47963, 2020 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31721415
6.
Dynamics of IFN-ß Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies.
Am J Respir Crit Care Med
; 201(1): 83-94, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31461630
7.
Human Lung Conventional Dendritic Cells Orchestrate Lymphoid Neogenesis during Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 202(4): 535-548, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32255375
8.
Use of precision cut lung slices as a translational model for the study of lung biology.
Respir Res
; 20(1): 162, 2019 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31324219
9.
MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling.
Cell Commun Signal
; 17(1): 78, 2019 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319869
10.
A Disintegrin and A Metalloproteinase-9 (ADAM9): A Novel Proteinase Culprit with Multifarious Contributions to COPD.
Am J Respir Crit Care Med
; 2018 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29864380
11.
A Disintegrin and Metalloproteinase Domain-8: A Novel Protective Proteinase in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 198(10): 1254-1267, 2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750543
12.
AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNFα with Minimal Systemic Exposure.
J Pharmacol Exp Ther
; 365(3): 567-572, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29549158
13.
Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 192(6): 706-18, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26266827
14.
Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.
Am J Respir Crit Care Med
; 188(3): 343-55, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23742729
15.
Design, Synthesis, and Biological Evaluation of MEK PROTACs.
J Med Chem
; 63(1): 157-162, 2020 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31804822
16.
Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPD.
Int J Chron Obstruct Pulmon Dis
; 14: 2611-2624, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32063702
17.
Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
Int J Chron Obstruct Pulmon Dis
; 13: 1279-1288, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29719383
18.
HRV16 Impairs Macrophages Cytokine Response to a Secondary Bacterial Trigger.
Front Immunol
; 9: 2908, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30619272
19.
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Int J Chron Obstruct Pulmon Dis
; 13: 1009-1019, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29628759
20.
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials.
Int Forum Allergy Rhinol
; 12(9): 1191-1195, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34970860